Pharmaceutical products

SOCIETA' REGIONALE PER LA SANITA' (SO.RE.SA. S.P.A.)·Naples, Italy·EUR 20000M·Deadline Dec 06, 2028 · 896 days left·Restricted·Supplies

Registrieren zum Speichern TED notice

High valueStructured notice only

Original notice title

Italy-Naples: Pharmaceutical products

70/100

Opportunity Score

PromisingMedium complexity

SuppliesOpen

Why this score?

Opportunity

70 / 100

Complexity

65 / 100

Risk factors

Only the notice and XML data are available; full procurement documents (specifications, contract terms, qualification c...

The high estimated value (€20 billion) is likely to attract many bidders, including large pharmaceutical companies, mak...

Restricted procedure — pre-qualification required

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Strong opportunity

Key Facts

EUR 20000M estimated value
Supplies contract
Supply of pharmaceutical products including medicines, blood derivatives, vaccines, and similar products.
Dynamic Purchasing System (DPS) covering healthcare authorities in Campania and potentially other Italian regions.

Show full summary

This notice announces the establishment of a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products (medicines, blood derivatives, vaccines, etc.) to healthcare authorities in the Campania region of Italy, with potential extension to other Italian regions. The DPS is managed by So.Re.Sa. S.p.A., the regional purchasing body. The procedure is restricted, and the estimated total value is €20 billion. The deadline for submission of initial tenders is 6 December 2028.

Risks

Only the notice and XML data are available; full procurement documents (specifications, contract terms, qualification c...

The high estimated value (€20 billion) is likely to attract many bidders, including large pharmaceutical companies, mak...

Restricted procedure — pre-qualification required

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.